The long-term prognosis for<unk>  is determined mainly by recurrent thrombosis, which may occur in up to 29% of patients, sometimes despite antithrombotic therapy.
Antiphospholipid syndrome
Protein C deficiency
Protein S deficiency
Catastrophic antiphospholipid syndrome
Acquired haemophilia
Antithrombin III deficiency
Sticky platelet syndrome
Congenital hypofibrinogenemia